ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Weight Control Drug Lorcaserin May Raise Cancer Risk drugs
January 16, 2020The prescription weight control medicine lorcaserin (Belviq, Belviq XR) may increase the risk for cancer, according to the results of a clinical trial assessing the safety of the drug, the U.S. Food and Drug Administration says.
Pharma Sources Insight January 2025
